Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial

PURPOSE: We compared dexamethasone 12 versus 6 mg daily for up to 10 days in patients with coronavirus disease 2019 (COVID-19) and severe hypoxaemia in the international, randomised, blinded COVID STEROID 2 trial. In the primary, conventional analyses, the predefined statistical significance thresho...

Descripción completa

Detalles Bibliográficos
Autores principales: Granholm, Anders, Munch, Marie Warrer, Myatra, Sheila Nainan, Vijayaraghavan, Bharath Kumar Tirupakuzhi, Cronhjort, Maria, Wahlin, Rebecka Rubenson, Jakob, Stephan M., Cioccari, Luca, Kjær, Maj-Brit Nørregaard, Vesterlund, Gitte Kingo, Meyhoff, Tine Sylvest, Helleberg, Marie, Møller, Morten Hylander, Benfield, Thomas, Venkatesh, Balasubramanian, Hammond, Naomi E., Micallef, Sharon, Bassi, Abhinav, John, Oommen, Jha, Vivekanand, Kristiansen, Klaus Tjelle, Ulrik, Charlotte Suppli, Jørgensen, Vibeke Lind, Smitt, Margit, Bestle, Morten H., Andreasen, Anne Sofie, Poulsen, Lone Musaeus, Rasmussen, Bodil Steen, Brøchner, Anne Craveiro, Strøm, Thomas, Møller, Anders, Khan, Mohd Saif, Padmanaban, Ajay, Divatia, Jigeeshu Vasishtha, Saseedharan, Sanjith, Borawake, Kapil, Kapadia, Farhad, Dixit, Subhal, Chawla, Rajesh, Shukla, Urvi, Amin, Pravin, Chew, Michelle S., Wamberg, Christian Aage, Gluud, Christian, Lange, Theis, Perner, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579417/
https://www.ncbi.nlm.nih.gov/pubmed/34757439
http://dx.doi.org/10.1007/s00134-021-06573-1

Ejemplares similares

Ejemplares similares